Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,251 | -61,660 | -255,134 | -173,771 | -99,922 |
| Depreciation Amortization | 1,536 | 724 | 3,114 | 1,787 | 1,146 |
| Accounts receivable | -10,832 | -7,038 | -3,570 | N/A | N/A |
| Accounts payable and accrued liabilities | -9,519 | -8,676 | 2,457 | -2,977 | -8,326 |
| Other Working Capital | -19,198 | -64,104 | 584,611 | 629,409 | -16,642 |
| Other Operating Activity | 44,686 | 27,577 | 39,150 | 9,123 | 13,168 |
| Operating Cash Flow | $-76,578 | $-113,177 | $370,628 | $463,571 | $-110,576 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 23,125 | N/A | N/A |
| PPE Investments | -94,448 | N/A | -1,773 | -1,036 | -734 |
| Purchase Of Investment | -361 | -78,426 | -63,824 | -47,562 | -28,874 |
| Sale Of Investment | 7,035 | 4,035 | 33,261 | 18,235 | 14,785 |
| Investing Cash Flow | $-87,774 | $-74,391 | $-9,211 | $-30,363 | $-14,823 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 245,000 | 200,000 | 140,000 |
| Common Stock Issued | 15,135 | 4,135 | 6,709 | 5,284 | 3,578 |
| Other Financing Activity | 0 | 0 | -13,664 | 0 | 0 |
| Financing Cash Flow | $15,135 | $4,135 | $238,045 | $205,284 | $143,578 |
| Beginning Cash Position | 677,480 | 677,480 | 78,018 | 78,018 | 78,018 |
| End Cash Position | 528,263 | 494,047 | 677,480 | 716,510 | 96,197 |
| Net Cash Flow | $-149,217 | $-183,433 | $599,462 | $638,492 | $18,179 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,578 | -113,177 | 370,628 | 463,571 | -110,576 |
| Capital Expenditure | -94,448 | N/A | -1,773 | -1,036 | -734 |
| Free Cash Flow | -171,026 | -113,177 | 368,855 | 462,535 | -111,310 |